Pharmacological chaperones restore proteostasis of epilepsy-associated GABAA receptor variants.
Pharmacological chaperones restore proteostasis of epilepsy-associated GABAA receptor variants.
复制标题
药理学伴侣可恢复癫痫相关 GABAA 受体变体的蛋白质稳态。
DOI:
10.1101/2023.04.18.537383
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Mu,Ting-Wei
中科院分区:
文献类型:
--
作者:
Wang,Ya-Juan;Seibert,Hailey;Ahn,LucieY;Schaffer,AshleighE;Mu,Ting-Wei
Recent advances in genetic diagnosis identified variants in genes encoding GABAAreceptors as causative for genetic epilepsy. Here, we selected eight disease-associated variants in the α1 subunit of GABAAreceptors causing mild to severe clinical phenotypes and showed that they are loss of function, mainly by reducing the folding and surface trafficking of the α1 protein. Furthermore, we sought client protein-specific pharmacological chaperones to restore the function of pathogenic receptors. Applications of positive allosteric modulators, including Hispidulin and TP003, increase the functional surface expression of the α1 variants. Mechanism of action study demonstrated that they enhance the folding, assembly, and trafficking and reduce the degradation of GABAAvariants without activating the unfolded protein response in HEK293T cells and human iPSC-derived neurons. Since these compounds cross the blood-brain barrier, such a pharmacological chaperoning strategy holds great promise to treat genetic epilepsy in a GABAAreceptor-specific manner.